Proficio Capital Partners’s Kyntra Bio KYNB Stock Holding History

Proficio Capital Partners’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4	Closed	-$4K	–	625
2019 Q2	$4K	Buy	+4	New	+$4.38K	﹤0.01%	1282

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Proficio Capital Partners's KYNB Position: Q3 2019 in Review

Proficio Capital Partners sold out of Kyntra Bio (KYNB) in Q3 2019, closing a stake of 4 shares — an estimated $4K sold.

Proficio Capital Partners first reported a position in KYNB in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 210 funds tracked by Wall St. Rank hold KYNB as of Q3 2019.

Proficio Capital Partners reported no remaining Kyntra Bio position as of Q3 2019 after selling out during the quarter.
Proficio Capital Partners sold 4 Kyntra Bio shares in Q3 2019, an estimated $4K.
Proficio Capital Partners first reported a position in Kyntra Bio in Q2 2019 and held it in 1 quarter.
Proficio Capital Partners's Kyntra Bio position peaked at $4K in Q2 2019.
210 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.